Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026.
New Gentle Methyl Conversion Kit Delivers High-Accuracy Profiling from as Little as 100 pg of DNA
Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official commercial launch of its SuperMethyl™ Max.
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
B-Body ® platform complements Twist’s antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeutics Platform to power high-throughput characterization of bispecific antibodies to fuel AI-enabled and traditional drug discovery
Singular Genomics Launches G4X™ in the U.S., Delivering Industry-Leading Throughput for In Situ Multiomics, Targets Translational and Clinical Applications
Singular Genomics announces U.S. commercial launch of the G4X™ Spatial Sequencer, a high-throughput platform for spatial multiomics from FFPE tissue with nearly 10× the throughput of competing systems.
AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality
AGC Biologics is manufacturing an mRNA therapy for Repair Biotechnologies to tackle one of the world’s most persistent health challenges and cause of mortality.
Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer’s Disease at CTAD 2025
New clinical data highlights circular RNAs (circRNAs) as a novel, non-invasive blood biomarker platform for the early detection of Alzheimer’s Disease (AD). The research demonstrates that circRNAs offer comprehensive insights into the multiple disrupted disease pathways central to AD’s biology and pathology.
LifeNet Health Honors Recovery Partners with 2025 Excellence Awards
VIRGINIA BEACH, Va., Nov. 5, 2025 /PRNewswire/ — LifeNet Health proudly announces the recipients of its 2025 Partnership Excellence Awards, celebrating the extraordinary individuals and teams whose expertise and dedication transform tissue donations into lifesaving and life-enhancing gifts.
Alabama Genomic Health Initiative reaches 10,000-participant mark, a genomic medicine milestone for Alabama
More than 10,000 Alabamians have received genetic testing that could change the course of their health through the Alabama Genomic Health Initiative.
Broad Clinical Labs Sets New GUINNESS WORLD RECORDS™ Title for Fastest DNA Sequencing Technique
BOSTON, Oct. 16, 2025 /PRNewswire/ — Broad Clinical Labs (BCL), in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, today announced official recognition by Guinness World Records for achieving the fastest DNA sequencing technique to date.
Ellis Bio and UChicago Announce Breakthrough Ultra-Mild Bisulfite Sequencing Technology
NEEDHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the Company will present insights from its enLIGHTEN™ Discovery Platform, and additional data from the CAN-2409 (aglatimagene besadenovec) program in non-small cell lung cancer (NSCLC), through two accepted poster presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Anniversary Annual Meeting, taking place November 5-9, 2025 in National Harbor, Maryland.